The reason for this discrepant finding between normal and cancer tissues may be related to the fact that cyclin D2 is a direct target of Myc in which its expression is further controlled by β-catenin (He et al, 1998; Bouchard et al, 1999). The gene discussed is MYC; the disease is cancer.